VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
VERU INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.31+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $53.25M
- P/E (TTM)
- –
- Dividend yield
- –
VERU INC. revenue by segment
By business segment
By product or service
| Revenue | Q4 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FC2, U.S. Prescription Channel [Member] | – | – | – | $597.31K | $633.72K | $651.38K | $863.38K | $4.15M | $163.00K | $322.19K | $6.74M | $11.59M | – | – |
| FC2, Global Public Health Sector [Member] | – | – | – | $3.54M | $1.51M | $3.21M | $2.48M | $2.43M | $2.34M | $2.26M | $2.87M | $1.44M | – | – |
| FC2 [Member] | – | – | – | $4.14M | $2.14M | $3.86M | $3.34M | $6.58M | $2.50M | $2.59M | $9.60M | $13.03M | – | – |
| ENTADFI [Member] | – | – | – | – | – | – | – | $5.52K | $7.79K | – | – | – | – | – |
| Other [Member] | – | – | – | – | – | – | -$225 | $5.52K | – | – | – | – | – | – |
| FC2 Female Condom [Member] | – | $6.66M | $3.95M | – | – | $3.86M | $3.34M | – | – | – | – | – | – | – |
| ENTADFI Capsules [Member] | – | – | $0 | – | – | – | -$225 | – | – | – | – | – | – | – |
By region
| Revenue | Q4 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Countries [Member] | – | – | – | $865.11K | $784.64K | $2.54M | $1.28M | $470.31K | $1.44M | $1.94M | $2.58M | $1.18M | – | – |
| United States | – | $1.65M | $1.11M | $1.24M | $1.36M | $1.32M | $1.45M | $4.79M | $809.38K | $649.96K | $7.02M | $11.85M | – | – |
| Uganda | – | – | – | – | – | – | – | – | $257.47K | – | – | – | – | – |
| South Africa | – | $724.95K | $0 | $1.18M | – | $0 | $612.00K | $1.33M | – | – | – | – | – | – |
| Other Geographical Areas [Member] | – | $1.52M | $1.53M | – | – | $2.54M | $1.28M | – | – | – | – | – | – | – |
| Mozambique | – | $0 | $1.32M | $855.36K | – | – | – | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of VERU's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.